Delirium Management: Are you Pro- or “Anti-“ Psychotic?

<p>Abby K. Hendricks, Pharm.D., (<a href='https://twitter.com/HendricksPharmD'>@HendricksPharmD</a>) identifies risk factors for the development of delirium, discusses literature assessing the use of antipsychotics for delirium in various patient populations and describes treatment options for managing delirious patients. </p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>